BioPharma Credit PLC

BOPCF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$72,783$50,340$71,838$37,523
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$32,375$6,332-$16,690$31,126
Other Non-Cash-$6,652$7,597-$7,505$24,127
Operating Cash Flow$33,756$64,269$47,643$92,776
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$15,000$0$0$1
Inv. Sales/Matur.$85,000$39,072$39,073$0
Other Inv. Act.$0-$39,073$0$0
Investing Cash Flow$70,000-$1$39,073$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.-$51,181-$29,126-$76,627-$2,797
Dividends Paid-$53,915-$66,664-$107,998-$22,797
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$105,096-$95,790-$184,625-$25,594
Forex Effect$25-$2$0-$7
Net Chg. in Cash-$1,315-$31,524-$97,909$67,176
Supplemental Information
Beg. Cash$5,620$37,144$135,053$67,877
End Cash$4,305$5,620$37,144$135,053
Free Cash Flow$33,756$64,269$47,643$92,776